Objective. To establish the prevalence of the various subtypes of Von
Willebrand's disease (VWD) among patients with bleeding disorders in t
he Western Cape and to review appropriate treatment strategies, Design
. A systematic clinical and laboratory study, Setting, Haemophilia cli
nics at two tertiary referral hospitals (Groote Schuur Hospital and Re
d Cross War Memorial Children's Hospital) in the Western Cape.Patients
. Twenty-two patients (14 females, 8 males; ages 3-55 years) were stud
ied. Those studied were selected for reasons of convenience, as they w
ere compliant and regular attenders at the clinics. Main outcome measu
res. History of a bleeding tendency; bleeding time measurements; facto
r VIII assays, von Willebrand factor (VWF) antigen assays; ristocetin
co-factor assays and VWF multimer analysis. Results. Fourteen patients
had typical type I VWD; 2 had type II and 5 had type III variants, an
d there was 1 unclassifiable variant, Analysis of local factor VIII co
ncentrates showed the presence of high-molecular-weight VWF multimers.
Conclusion. The results are similar to patterns reported elsewhere in
the world. Locally produced factor VIII concentrates, unlike a number
of commercially produced concentrates, contain sufficient multimers f
or use as appropriate replacement therapy.